Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.10%
SPX
+0.38%
IXIC
+0.59%
FTSE
-0.47%
N225
-0.34%
AXJO
0.00%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
Health Care
nuvb
Nuvation Bio
NYSE: NUVB
+2.45 (+50.94%)
7.245
USD
At close at Nov 19, 20:43 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Nuvation Bio Faces Investigation for Alleged Fiduciary Breaches Amid Shareholder Concerns

9 months ago
publisher logo
Cashu

Nuvation Bio Launches Access Program for Taletrectinib in ROS1-Positive Lung Cancer Patients

10 months ago
publisher logo
Cashu

Nuvation Bio Launches Expanded Access Program for Taletrectinib in ROS1-Positive NSCLC Patients

10 months ago

Latest Nuvation Bio News

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

Feature Image for interests on Bzi-Tfm, Healthcare, Movers, Stock from benzinga.com
about 4 hours ago
benzinga.com

Earnings Scheduled For November 3, 2025

Feature Image for interests on Basic Materials, Bzi-Ue, Communication Services, Consumer Cyclical from benzinga.com
16 days ago
benzinga.com

United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday

Feature Image for interests on Big Gainers, Consumer Defensive, Financial Services, Healthcare from benzinga.com
about 2 months ago
benzinga.com

Analyst Expectations For Nuvation Bio's Future

2 months ago
prnewswire.com

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up

Feature Image for interests on Banking & Financial Services, Biotechnology, Health Care & Hospitals, Investments Opinions from prnewswire.com
4 months ago
benzinga.com

Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval

Feature Image for interests on Biotech, Briefs, News, Stock from benzinga.com
5 months ago
prnewswire.com

Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm

Feature Image for interests on Kuehn Law, Pllc, Stock, Unknown Sector from prnewswire.com
9 months ago
businesswire.com

Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer

Feature Image for interests on Stock, Unknown Sector from businesswire.com
10 months ago
businesswire.com

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Feature Image for interests on Stock, Unknown Sector from businesswire.com
11 months ago
businesswire.com

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

Feature Image for interests on China, Consumer Defensive, Financial Services, Stock from businesswire.com
11 months ago
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.